These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Reflexphotometric determinations of vasoconstriction after topical application of steroids. Method, reliability, errors (author's transl)]. Zaun H; Altmeyer P Arch Dermatol Forsch; 1973; 247(4):379-86. PubMed ID: 4767633 [No Abstract] [Full Text] [Related]
29. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay. Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415 [TBL] [Abstract][Full Text] [Related]
30. [Animal experiment studies on the local activity of 9-alpha-fluoro-16-alpha-methyl-17-desoxy-prednisolone]. Schröder HG; Babej M; Vogel HG Arzneimittelforschung; 1974 Jan; 24(1):3-5. PubMed ID: 4406107 [No Abstract] [Full Text] [Related]
31. Vasoconstrictor and systemic activities of topical steroids. Child KJ; English AF; Gilbert HG; Hewitt A; Woollett EA Arch Dermatol; 1968 Apr; 97(4):407-10. PubMed ID: 4966856 [No Abstract] [Full Text] [Related]
32. Evaluation of corticosteroids intended for use as topical anti-inflammatory drugs. Bagatell FK; Augustine MA Curr Ther Res Clin Exp; 1974 Jul; 16(7):748-57. PubMed ID: 4210465 [No Abstract] [Full Text] [Related]
33. Bioassay system for formulations of topically applied glucocorticosteroids. Stoughton RB Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246 [No Abstract] [Full Text] [Related]
34. [Comparative studies in man on the percutaneous absorption of diflucortolone valerate, betamethasone-17-valerate, beclomethasone dipropionate and fluocinolone acetonide]. Täuber VU; Amin M; Fuchs P; Speck U Arzneimittelforschung; 1976; 26(7b):1492-5. PubMed ID: 1036945 [TBL] [Abstract][Full Text] [Related]
35. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 2. Anti-inflammatory and anti-lymphocyte activities. Young JM; Wagner BM; Fisk RA Br J Dermatol; 1978 Dec; 99(6):665-73. PubMed ID: 737129 [TBL] [Abstract][Full Text] [Related]
36. Beneficial pharmacological effects of selective glucocorticoid receptor agonist in external eye diseases. Kato M; Hagiwara Y; Oda T; Imamura-Takai M; Aono H; Nakamura M J Ocul Pharmacol Ther; 2011 Aug; 27(4):353-60. PubMed ID: 21574866 [TBL] [Abstract][Full Text] [Related]
37. A comparison of techniques to assess skin blanching following the topical application of glucocorticoids. Noon JP; Evans CE; Haynes WG; Webb DJ; Walker BR Br J Dermatol; 1996 May; 134(5):837-42. PubMed ID: 8736322 [TBL] [Abstract][Full Text] [Related]
38. The stability and blanching efficacy of betamethasone-17-valerate in emulsifying ointment. Ryatt KS; Feather JW; Mehta A; Dawson JB; Cotterill JA; Swallow R Br J Dermatol; 1982 Jul; 107(1):71-6. PubMed ID: 7104209 [TBL] [Abstract][Full Text] [Related]
39. [Testing the loss of efficacy (tachyphylaxis) during external steroid application]. Koch EM; Jurgovsky E Hautarzt; 1985 Mar; 36(3):146-9. PubMed ID: 3997512 [TBL] [Abstract][Full Text] [Related]
40. [Biotransformation of diflucortolone valerate in the skin of rat, guinea pig and man (author's transl)]. Täuber VU; Toda T Arzneimittelforschung; 1976; 26(7b):1484-7. PubMed ID: 1036940 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]